LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

DFT study of Ni-doped graphene nanosheet as a drug carrier for multiple sclerosis drugs

Photo from wikipedia

Abstract The adsorption of Ampyra, Cladribine, and Cyclophosphamide multiple sclerosis drugs on the surface of Ni-doped graphene nanosheet was investigated using DFT calculations in the liquid phase. The adsorption energies… Click to show full abstract

Abstract The adsorption of Ampyra, Cladribine, and Cyclophosphamide multiple sclerosis drugs on the surface of Ni-doped graphene nanosheet was investigated using DFT calculations in the liquid phase. The adsorption energies and some chemical properties like HOMO and LOMO energy levels, energy gap, chemical hardness, chemical potential, electrophilicity index, and dipole moment were assigned for different configurations of G-Ni-drug. The obtained negative values of adsorption energies for all considered G-Ni-drug complexes ranged from -25.16 to -110.77 Kcal mol-1 which indicating the process of adsorption on the G-Ni surface was exothermic and thermodynamically favorable. The AIM analysis illustrated the existence of closed-shell interactions between the G-Ni nanosheet and drug molecules. Based on NBO outcomes, the drug molecules and G-Ni nanosheet behaved as donor and acceptor of the electron, respectively. The obtained results indicated that G-Ni had a stronger interaction with Clad drug and could be a prominent carrier for Clad drug.

Keywords: doped graphene; nanosheet drug; drug; multiple sclerosis; sclerosis drugs; graphene nanosheet

Journal Title: Computational and Theoretical Chemistry
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.